The CH24H metabolite, 24HC, blocks viral entry by disrupting intracellular cholesterol homeostasis

[1]  Yuan Zhang,et al.  Trim25 restricts rabies virus replication by destabilizing phosphoprotein , 2022, Cell insight.

[2]  U. Rescher,et al.  Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro , 2021, Emerging microbes & infections.

[3]  G. Gao,et al.  Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19 , 2021, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.

[4]  Saliha Majdoul,et al.  Lessons in self-defence: inhibition of virus entry by intrinsic immunity , 2021, Nature Reviews Immunology.

[5]  Birsen Can Demirdöğen,et al.  Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population , 2021, Neurological Sciences.

[6]  N. Cartier,et al.  Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications , 2021, Frontiers in Aging Neuroscience.

[7]  F. Lamari,et al.  Plasma oxysterols: Altered level of plasma 24-hydroxycholesterol in patients with bipolar disorder , 2021, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  S. Ludwig,et al.  Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro , 2021, British journal of pharmacology.

[9]  B. Weynand,et al.  Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial , 2021, EBioMedicine.

[10]  Juan Pu,et al.  The Role of Lipid Metabolism in Influenza A Virus Infection , 2021, Pathogens.

[11]  E. Nelson,et al.  Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry , 2021, Nature Structural & Molecular Biology.

[12]  S. Farhadian,et al.  Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2021, The Journal of experimental medicine.

[13]  C. Jallet,et al.  Broad spectrum compounds targeting early stages of RABV infection. , 2021, Antiviral research.

[14]  Shihao Ding,et al.  Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis , 2021, Gut microbes.

[15]  Paul J. Ackerman,et al.  SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation , 2020, bioRxiv.

[16]  S. Ciesek,et al.  In vitro activity of itraconazole against SARS‐CoV‐2 , 2020, bioRxiv.

[17]  Y. Izumi,et al.  Effects of CYP46A1 Inhibition on Long-Term-Depression in Hippocampal Slices ex vivo and 24S-Hydroxycholesterol Levels in Mice in vivo , 2020, Frontiers in Molecular Neuroscience.

[18]  A. Sodero.  24S‐hydroxycholesterol: Cellular effects and variations in brain diseases , 2020, Journal of neurochemistry.

[19]  T. Rana,et al.  Cholesterol 25‐Hydroxylase inhibits SARS‐CoV‐2 and other coronaviruses by depleting membrane cholesterol , 2020, The EMBO journal.

[20]  G. Cheng,et al.  25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor , 2020, Cell Research.

[21]  A. El Idrissi,et al.  Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients , 2020, Neurological Sciences.

[22]  S. Farhadian,et al.  Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2020, bioRxiv.

[23]  J. Seibel,et al.  The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue , 2020, Scientific Reports.

[24]  D. Fremont,et al.  Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion , 2020, Proceedings of the National Academy of Sciences.

[25]  X. Shu,et al.  Gypenosides mediate cholesterol efflux and suppress oxidized LDL induced inflammation in retinal pigment epithelium cells. , 2020, Experimental eye research.

[26]  S. Ludwig,et al.  Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine , 2020, bioRxiv.

[27]  Wei Jiang,et al.  Ets2 suppresses inflammatory cytokines through MAPK/NF-κB signaling and directly binds to the IL-6 promoter in macrophages , 2019, Aging.

[28]  Z. Fu,et al.  Cholesterol 25-hydroxylase suppresses rabies virus infection by inhibiting viral entry , 2019, Archives of Virology.

[29]  J. Caboche,et al.  CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease. , 2019, Brain : a journal of neurology.

[30]  I. Pikuleva,et al.  Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases , 2019, Neurotherapeutics.

[31]  S. Ludwig,et al.  The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo , 2019, Emerging microbes & infections.

[32]  G. Poli,et al.  25-Hydroxycholesterol and 27-hydroxycholesterol inhibit human rotavirus infection by sequestering viral particles into late endosomes , 2018, Redox biology.

[33]  M. Tabaton,et al.  A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1 , 2018, Redox biology.

[34]  Y. Gaudin,et al.  Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein , 2018, Nature Communications.

[35]  D. Streicker,et al.  The spread and evolution of rabies virus: conquering new frontiers , 2018, Nature Reviews Microbiology.

[36]  D. McGavern,et al.  New advances in CNS immunity against viral infection , 2017, Current Opinion in Virology.

[37]  Yidi Guo,et al.  Rabies virus co-localizes with early (Rab5) and late (Rab7) endosomal proteins in neuronal and SH-SY5Y cells , 2017, Virologica Sinica.

[38]  Ping Liu,et al.  25‐Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model , 2017, Immunity.

[39]  B. McEwen,et al.  Nuclear receptor REV-ERBα mediates circadian sensitivity to mortality in murine vesicular stomatitis virus-induced encephalitis , 2016, Proceedings of the National Academy of Sciences.

[40]  Y. Izumi,et al.  24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival , 2016, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[41]  Alan S. Brown,et al.  Neurotropic virus infections as the cause of immediate and delayed neuropathology , 2015, Acta Neuropathologica.

[42]  R. Miles,et al.  CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease. , 2015, Brain : a journal of neurology.

[43]  D. Srilatha,et al.  Effects of Metabolic syndrome , 2015 .

[44]  Chiou-Lian Lai,et al.  Effects of metabolic syndrome, apolipoprotein E, and CYP46 on cognition among Taiwanese Chinese , 2014, The Kaohsiung journal of medical sciences.

[45]  S. Whelan,et al.  Uptake of Rabies Virus into Epithelial Cells by Clathrin-Mediated Endocytosis Depends upon Actin , 2013, Journal of Virology.

[46]  A. Cedazo-Mínguez,et al.  Is It Possible to Improve Memory Function by Upregulation of the Cholesterol 24S-Hydroxylase (CYP46A1) in the Brain? , 2013, PloS one.

[47]  Jae U. Jung,et al.  The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry , 2013, Cell Host & Microbe.

[48]  Benhur Lee,et al.  The greasy response to virus infections. , 2013, Cell host & microbe.

[49]  A. Werman,et al.  LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus , 2013, Proceedings of the National Academy of Sciences.

[50]  V. Leoni,et al.  24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. , 2013, Biochimie.

[51]  G. Cheng,et al.  Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. , 2013, Immunity.

[52]  D. Vock,et al.  Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype‐specific manner , 2012, Hepatology.

[53]  J. Dye,et al.  Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 , 2011, Nature.

[54]  Kevin A. Robertson,et al.  Host Defense against Viral Infection Involves Interferon Mediated Down-Regulation of Sterol Biosynthesis , 2011, PLoS biology.

[55]  W. Prinz,et al.  The diverse functions of oxysterol-binding proteins. , 2010, Annual review of cell and developmental biology.

[56]  S. Whelan,et al.  The Length of Vesicular Stomatitis Virus Particles Dictates a Need for Actin Assembly during Clathrin-Dependent Endocytosis , 2010, PLoS pathogens.

[57]  N. Johnson,et al.  The immune response to rabies virus infection and vaccination. , 2010, Vaccine.

[58]  H. Fukada,et al.  Electrostatic Interaction between Oxysterol-binding Protein and VAMP-associated Protein A Revealed by NMR and Mutagenesis Studies* , 2010, The Journal of Biological Chemistry.

[59]  C. W. Tam,et al.  Cholesterol 24‐hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two‐year follow up study , 2009, International journal of geriatric psychiatry.

[60]  J. Gruenberg.  Viruses and endosome membrane dynamics. , 2009, Current opinion in cell biology.

[61]  D. Russell,et al.  Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. , 2009, Annual review of biochemistry.

[62]  S. Whelan,et al.  Vesicular Stomatitis Virus Enters Cells through Vesicles Incompletely Coated with Clathrin That Depend upon Actin for Internalization , 2009, PLoS pathogens.

[63]  J. Gruenberg,et al.  The ESCRT‐I Subunit TSG101 Controls Endosome‐to‐Cytosol Release of Viral RNA , 2008, Traffic.

[64]  A. Helenius,et al.  Vesicular Stomatitis Virus Entry Host Cell Factors and Functions Involved In , 2022 .

[65]  J. Holthuis,et al.  Lipid traffic: floppy drives and a superhighway , 2005, Nature Reviews Molecular Cell Biology.

[66]  M. Chow,et al.  Cholesterol Removal by Methyl-β-Cyclodextrin Inhibits Poliovirus Entry , 2004, Journal of Virology.

[67]  J. Fazakerley.  Pathogenesis of Semliki Forest virus encephalitis. , 2002, Journal of neurovirology.

[68]  M. Schachner,et al.  The Neural Cell Adhesion Molecule Is a Receptor for Rabies Virus , 1998, Journal of Virology.

[69]  Michael Karin.  Mitogen‐Activated Protein Kinase Cascades as Regulators of Stress Responses , 1998, Annals of the New York Academy of Sciences.

[70]  P. Dawson,et al.  Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding , 1992, The Journal of cell biology.

[71]  T. Lentz,et al.  Is the acetylcholine receptor a rabies virus receptor? , 1982, Science.

[72]  C. Boschek,et al.  Semliki forest virus: cause of a fatal case of human encephalitis. , 1979, Science.

[73]  R. Miles,et al.  CYP 46 A 1 inhibition , brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer ’ s disease , 2015 .

[74]  Xuping Xie,et al.  U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. , 2012, Antiviral research.

[75]  G. Anderluh,et al.  Kinetics of cholesterol extraction from lipid membranes by methyl-beta-cyclodextrin--a surface plasmon resonance approach. , 2008, Biochimica et biophysica acta.

[76]  N. Demaurex,et al.  Endosome-to-cytosol transport of viral nucleocapsids , 2005, Nature Cell Biology.

[77]  R. Palmiter,et al.  Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport , 1999, Nature Cell Biology.